Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)
AUTOR(ES)
Manzano, Roberta P A
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1955569Documentos Relacionados
- Non‐responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions
- Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin)
- Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness
- Uso do bevacizumab (Avastin®) na síndrome KID: relato de caso
- The effects of the subconjunctival injection of bevacizumab (Avastin®) on angiogenesis in the rat cornea